Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 061250124 approvals1 trials

HWAIL PHARM. CO., LTD

Official website

Founded in 1980 and listed on the KOSDAQ in 2002, Hwail Pharm specializes in active pharmaceutical ingredients and cephalosporin antibiotic finished drugs.

Price

Change

Market cap

Products & technology

  • Active and inactive pharmaceutical ingredients (API/IPI)Raw materials for cardiovascular, antibacterial, gastrointestinal, respiratory, and anticancer drugs
  • Cephalosporin antibioticsFinished pharmaceutical (beta-lactam antibiotic)
  • Functional health food ingredients (red ginseng, aloe, ginseng, etc.)Health functional food ingredient

Regulatory approvals

data.go.kr

124 Korean MFDS drug approvals · 2002–2022

  • MFDS drugDaparsi Tab 10/100mg2022-01-12
    Drug · Prescription · Approval202200214
  • MFDS drugAtoeve Tab. 10/10mg2021-01-08
    Drug · Prescription · Approval202100227
  • MFDS drugAtoeve Tab. 10/40mg2021-01-08
    Drug · Prescription · Approval202100228
  • MFDS drugAtoeve Tab. 10/20mg2021-01-08
    Drug · Prescription · Approval202100229
  • MFDS drugHIALPHA Inj.2020-05-26
    Drug · Prescription · Approval202003838
  • MFDS drugTenodi tab.Revoked2020-01-08
    Drug · Prescription · Approval202000141
  • MFDS drugYouthcaine Cream(Lidicaine)2019-12-03
    Drug · OTC · Notification201908217
  • MFDS drugTernarine tabRevoked2019-11-20
    Drug · Prescription · Approval201908005
  • MFDS drugIrso tab.Revoked2019-11-11
    Drug · Prescription · Approval201907861
  • MFDS drugDagli-M Tab.Revoked2019-11-06
    Drug · Prescription · Approval201907770
  • MFDS drugSolifeni tab. 5mgRevoked2019-11-04
    Drug · Prescription · Approval201907703
  • MFDS drugSolifeni tab. 10mgRevoked2019-11-04
    Drug · Prescription · Approval201907704
Show 68 more
  • MFDS drugEso-MP Tab. 20mg2019-10-28
    Drug · Prescription · Approval201907479
  • MFDS drugEso-MP Tab. 40mg2019-10-28
    Drug · Prescription · Approval201907480
  • MFDS drugEscier tab. 20mgRevoked2019-10-18
    Drug · Prescription · Approval201907344
  • MFDS drugEscier tab. 10mgRevoked2019-10-18
    Drug · Prescription · Approval201907345
  • MFDS drugSuvatin Tab. 20mgRevoked2019-10-18
    Drug · Prescription · Approval201907349
  • MFDS drugHwacilta tab.Revoked2019-10-16
    Drug · Prescription · Approval201907279
  • MFDS drugHwalonal CR tab. 0.2mgRevoked2019-10-16
    Drug · Prescription · Approval201907283
  • MFDS drugFamoti Tab. 20mg2019-10-15
    Drug · Prescription · Approval201907237
  • MFDS drugBytarin tab. 10/20mgRevoked2019-10-15
    Drug · Prescription · Approval201907233
  • MFDS drugBytarin tab. 10/10mgRevoked2019-10-15
    Drug · Prescription · Approval201907234
  • MFDS drugExatin cap. 150mgRevoked2019-10-10
    Drug · Prescription · Approval201907154
  • MFDS drugAllestin Tab. 20mgRevoked2019-09-24
    Drug · Prescription · Approval201906695
  • MFDS drugSarpogre tab. 100mg2019-09-19
    Drug · Prescription · Approval201906564
  • MFDS drugRtos tab.Revoked2019-09-09
    Drug · Prescription · Approval201906370
  • MFDS drugEclofen CR Tab.2019-08-29
    Drug · Prescription · Approval201906178
  • MFDS drugNellcure nail lacquerRevoked2019-08-23
    Drug · OTC · Notification201905979
  • MFDS drugRivero cap. 3.0mgRevoked2019-08-07
    Drug · Prescription · Approval201905591
  • MFDS drugRivero cap. 1.5mgRevoked2019-08-07
    Drug · Prescription · Approval201905592
  • MFDS drugIrion tab. 10mgRevoked2019-07-18
    Drug · Prescription · Approval201904819
  • MFDS drugHwail tami cap. 30mgRevoked2019-07-17
    Drug · Prescription · Approval201904790
  • MFDS drugHwail tami cap. 45mgRevoked2019-07-17
    Drug · Prescription · Approval201904791
  • MFDS drugHwail tami cap. 75mgRevoked2019-07-17
    Drug · Prescription · Approval201904792
  • MFDS drugMemansa Tab. 10mg2019-06-04
    Drug · Prescription · Approval201903733
  • MFDS drugTelmilepine Tab. 80/5mg2019-05-21
    Drug · Prescription · Approval201903294
  • MFDS drugTelmilepine Tab. 40/5mg2019-05-21
    Drug · Prescription · Approval201903295
  • MFDS drugRebarid Tab. 100mg2019-04-23
    Drug · Prescription · Approval201902535
  • MFDS drugFinaseta Tab. 5mg2019-04-17
    Drug · Prescription · Approval201902353
  • MFDS drugFinaseta Tab. 1mgRevoked2019-03-29
    Drug · Prescription · Approval201901938
  • MFDS drugFloxen Cap.2018-12-20
    Drug · Prescription · Approval201805198
  • MFDS drugFloxen Cap. 10mgRevoked2018-12-20
    Drug · Prescription · Approval201805197
  • MFDS drugTopirai Tab. 100mg2018-10-31
    Drug · Prescription · Approval201804314
  • MFDS drugTopirai Tab. 25mg2018-10-31
    Drug · Prescription · Approval201804315
  • MFDS drugHwamocle Tab. 375mg2018-09-27
    Drug · Prescription · Approval201803807
  • MFDS drugHwail Cefotaxime Sodium Inj. 1g2018-09-20
    Drug · Prescription · Notification201803771
  • MFDS drugEldosteine Cap.2018-08-28
    Drug · OTC · Notification201803487
  • MFDS drugFreshview Beta2016-08-23
    Drug · OTC · Notification201605059
  • MFDS drugZincete Tab. 250mg2016-03-09
    Drug · Prescription · Approval201601374
  • MFDS drugHwamocle Tab. 625mg2015-12-31
    Drug · Prescription · Approval201508548
  • MFDS drugDoneone Tab 5mg2015-12-28
    Drug · Prescription · Approval201508435
  • MFDS drugDoneone Tab. 10mg2015-12-28
    Drug · Prescription · Approval201508436
  • MFDS drugSuvatin Tab. 10mg2015-12-28
    Drug · Prescription · Approval201508442
  • MFDS drugHwatiren Tab.Revoked2015-11-23
    Drug · Prescription · Notification201507801
  • MFDS drugMosagood Tab.2015-11-05
    Drug · Prescription · Approval201507615
  • MFDS drugAmlobesil 5mg2015-08-24
    Drug · Prescription · Approval201505922
  • MFDS drugRabetop Tab. 10mg2015-07-29
    Drug · Prescription · Approval201505133
  • MFDS drugRabetop Tab. 20mg2015-07-29
    Drug · Prescription · Approval201505134
  • MFDS drugNewbrex Cap. 200mg2015-06-29
    Drug · Prescription · Approval201504176
  • MFDS drugHwaroxo tab.2015-05-15
    Drug · Prescription · Approval201502959
  • MFDS drugAlgi-A sol.2015-03-31
    Drug · Prescription · Notification201501701
  • MFDS drugTendanamin Cap.2015-02-09
    Drug · OTC · Notification201500662
  • MFDS drugEntevir tab. 0.5mg2014-07-30
    Drug · Prescription · Approval201403512
  • MFDS drugEntevir tab. 1.0mgRevoked2014-07-30
    Drug · Prescription · Approval201403511
  • MFDS drugHwail levofloxacin ophthalmic(levofloxacin)2014-07-14
    Drug · Prescription · Notification201403115
  • MFDS drugHwail cefotiam inj. 1g2014-07-10
    Drug · Prescription · Notification201403089
  • MFDS drugLoxical Cap.2014-05-28
    Drug · Prescription · Approval201402419
  • MFDS drugEporin Tab.2014-05-26
    Drug · Prescription · Approval201402374
  • MFDS drugAbatin Tab. 20mg2014-03-18
    Drug · Prescription · Approval201401233
  • MFDS drugNotongpen plus mini Tab.2013-12-04
    Drug · Prescription · Approval201310500
  • MFDS drugFulocan cap.2013-11-15
    Drug · Prescription · Approval201310137
  • MFDS drugHwail Roxithromycin Tab.2013-10-10
    Drug · Prescription · Approval201309610
  • MFDS drugEclopen Tab.2013-09-30
    Drug · Prescription · Approval201309500
  • MFDS drugOflar Tab.2013-09-23
    Drug · Prescription · Approval201309390
  • MFDS drugDagli Tab2013-07-31
    Drug · Prescription · Approval201308597
  • MFDS drugAbatin Tab. 10mg2013-07-19
    Drug · Prescription · Approval201308307
  • MFDS drugLesunny Tab.2013-05-14
    Drug · Prescription · Approval201307338
  • MFDS drugMediron Tab.2013-01-25
    Drug · Prescription · Approval201302240
  • MFDS drugCloje Tab.2013-01-18
    Drug · Prescription · Approval201301620
  • MFDS drugCophemin soft cap.Revoked2012-03-14
    Drug · OTC · Notification201201600

Showing the 80 most recent of 124 records.

Clinical trials

data.go.kr

1 MFDS clinical trial authorisations · 2014 (Bioequivalence 1)

  • Bioequivalence메디론정(메틸프레드니솔론)2014-05-26

    2 trial sites

R&D and key agreements

Source: DART corporate disclosure

의약품 원료 및 건강기능식품 개발 · The in-house research institute at the Pangyo office (Korea Bio Park Building C, 5th floor) develops pharmaceutical ingredients, including for new drugs, and health functional foods, with a research staff of 7, including 1 PhD and 6 master's degree holders.

Not yet compiled: business overview. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

HL GENOMICS Co., Ltd.85
Kolmar BioTech, Inc.85

Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition